ROCK2 promotes renal cell carcinoma progression by functioning as an RNA-binding protein regulating the PAI-1/NLRP3 axis and senescence escape
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Zhengdong Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, rho-Associated Kinases, Carcinoma, Renal Cell, Plasminogen Activator Inhibitor 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Guangzhou Medical University, National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Renal cell carcinoma (RCC) is an aggressive malignancy with limited treatment options at advanced stages. Although the incidence of RCC is increasing globally, the molecular mechanisms driving its progression remain poorly understood. In this study, we demonstrate that ROCK2 promotes RCC progression through post-transcriptional regulation of PAI-1. RNA sequencing and cytokine profiling of ROCK2-knockdown RCC cells revealed a significant decrease in PAI-1 expression. Overexpression of PAI-1 restored NLRP3 inflammasome activation, inhibited cellular senescence, and enhanced mitochondrial fission and autophagy, effects that were abolished by the NLRP3 inhibitor MCC950. In vivo, PAI-1 overexpression promoted tumor growth and suppressed both apoptosis and senescence, while NLRP3 inhibition reversed these effects. RNA immunoprecipitation assays confirmed that ROCK2 directly binds to PAI-1 mRNA, suggesting a post-transcriptional regulatory mechanism. Collectively, these results support a model in which ROCK2 facilitates RCC progression by stabilizing PAI-1 mRNA, thereby activating the NLRP3 inflammasome, inhibiting cellular senescence, and promoting mitochondrial remodeling, suggesting that the ROCK2/PAI-1/NLRP3 axis may serve as a potential therapeutic target for RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, Nanchang University, Nanchang, China.
- GIBH-Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China.
- Department of Urology, The People's Hospital of Le'an County, Fuzhou, China.
- GIBH-Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China. Electronic address: 2023210653@stu.gzhmu.edu.cn.
- GIBH-Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China. Electronic address: yuting.zhou@gzhmu.edu.cn.
- GIBH-Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China. Electronic address: yiqian.wang@gzhmu.edu.cn.
Förderung
- Guangzhou Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Hong, Z., Zeng, Y., Zhou, Q., Han, H., Guo, X., Zhu, W., Zhu, C., Luo, X., Zhou, Y., & Wang, Y. (2025). ROCK2 promotes renal cell carcinoma progression by functioning as an RNA-binding protein regulating the PAI-1/NLRP3 axis and senescence escape. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112154
Vancouver
Hong Z, Zeng Y, Zhou Q, Han H, Guo X, Zhu W, et al. ROCK2 promotes renal cell carcinoma progression by functioning as an RNA-binding protein regulating the PAI-1/NLRP3 axis and senescence escape. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112154
BibTeX
@article{Hong2025,
author = {Hong, Zhengdong and Zeng, Yinghui and Zhou, Qiang and Han, Hong and Guo, Xiaoke and Zhu, Weibin and Zhu, Cunlong and Luo, Xin and Zhou, Yuting and Wang, Yiqian},
title = {ROCK2 promotes renal cell carcinoma progression by functioning as an RNA-binding protein regulating the PAI-1/NLRP3 axis and senescence escape},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112154}
}
EUVIMED